These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21827011)
21. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy. Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844 [TBL] [Abstract][Full Text] [Related]
22. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas. Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091 [TBL] [Abstract][Full Text] [Related]
23. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848 [TBL] [Abstract][Full Text] [Related]
24. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells. Wang M; Xiao J; Jiang J; Qin R Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110 [No Abstract] [Full Text] [Related]
25. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma]. Bi CL; Fang JS; Chen FH; Wang YJ; Wu J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043 [TBL] [Abstract][Full Text] [Related]
26. Glioblastoma cancer stem cells--from concept to clinical application. Stopschinski BE; Beier CP; Beier D Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828 [TBL] [Abstract][Full Text] [Related]
27. Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity. Zhang B; Sun J; Yu SP; Chen C; Liu B; Liu ZF; Ren BC; Ming HL; Yang XJ Chin Med J (Engl); 2012 Dec; 125(24):4344-8. PubMed ID: 23253699 [TBL] [Abstract][Full Text] [Related]
28. [Spheres isolated from Colo205 cell line possess cancer stem-like cells under serum-free culture condition]. Li YF; Xiao B; Lai ZS; Tu SF; Wang YY; Zhang XL Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):236-40. PubMed ID: 18250051 [TBL] [Abstract][Full Text] [Related]
29. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells. Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410 [TBL] [Abstract][Full Text] [Related]
30. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. McCord AM; Jamal M; Shankavaram UT; Lang FF; Camphausen K; Tofilon PJ Mol Cancer Res; 2009 Apr; 7(4):489-97. PubMed ID: 19372578 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. Mizukami T; Kamachi H; Mitsuhashi T; Tsuruga Y; Hatanaka Y; Kamiyama T; Matsuno Y; Taketomi A BMC Cancer; 2014 Sep; 14():687. PubMed ID: 25240521 [TBL] [Abstract][Full Text] [Related]
32. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells. Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982 [TBL] [Abstract][Full Text] [Related]
33. [Isolation and characterization of brain tumor stem cells in human medulloblastoma]. Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595 [TBL] [Abstract][Full Text] [Related]
34. Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to an increase in a CD133-positive cell population in human glioblastomas in vitro. Kahlert UD; Maciaczyk D; Dai F; Claus R; Firat E; Doostkam S; Bogiel T; Carro MS; Döbrössy M; Herold-Mende C; Niedermann G; Prinz M; Nikkhah G; Maciaczyk J J Neuropathol Exp Neurol; 2012 Dec; 71(12):1086-99. PubMed ID: 23147506 [TBL] [Abstract][Full Text] [Related]
35. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice]. Song WC; Fei XF; Dong J Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405 [TBL] [Abstract][Full Text] [Related]
36. [Correlative study of distribution of brain tumor stem cell with micro-vascular system]. Li MW; Niu CS Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050 [TBL] [Abstract][Full Text] [Related]
38. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433 [TBL] [Abstract][Full Text] [Related]
39. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells. Choi SA; Wang KC; Phi JH; Lee JY; Park CK; Park SH; Kim SK Cancer Lett; 2012 Nov; 324(2):221-30. PubMed ID: 22652175 [TBL] [Abstract][Full Text] [Related]
40. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]